Leadership

Patrick Walsh

Patrick Walsh

Patrick Walsh served as CEO of Alcami on two previous occasions and has served as Chairman over the last four years. In addition to his duties at Alcami, he currently serves as Chairman of ANI Pharmaceuticals, Inc. (NASDAQ: ANIP), Chairman of MedPharm, and is an Operating Partner at Ampersand Capital Partners.

He joined Ampersand as an Operating Partner in 2018 and has been CEO of three Ampersand portfolio companies including Alcami, TriPharm Services and Avista Pharma. Pat has been involved in other Ampersand portfolio companies, serving as Chairman of Brammer Bio and a Director at MedPharm, Ltd. He has extensive experience directing pharmaceutical manufacturing and lab operations on a global scale in fill-finish, API, specialty pharmaceutical, formulation, manufacturing, and analytical contract development organizations. Over the course of his 42-year career in the healthcare industry, Patrick has been CEO of six pharma companies and served as a company director in fifteen healthcare organizations.

Patrick Walsh